Recombinant LbCas12a (cpf1)

Recombinant LbCas12a (cpf1)

Product No.: L321

- -
- -
Alternate Names
CRISPR associated protein 12a, Cpf1
Product Type
Recombinant Protein
Expression Host
E. coli Cells
Applications
ELISA
FA
WB

- -
- -
Select Product Size
- -
- -

Background

CRISPR-Cas12a (Cpf1) is a class II type V CRISPR system widely used for plant genome editing that relies on a short ~43 nt CRISPR RNA for DNA targeting 1. Cas12a proteins recognize T-rich protospacer adjacent motifs (PAM), with the canonical PAM being TTTV, and can be used in single gene or multiplex genome editing. Cas12a has RNase III activity 2 , enabling it to self-process the crRNA repeats, thereby enhancing its multiplexing ability 1. Cas12a cuts at distal sites from the PAM, generating staggered ends, and is more likely than Cas9 to cut and edit the target site repeatedly, which results in larger deletions or enhanced homology-directed repair than with Cas9 1. LbCas12a is derived from Lachnospiraceae bacterium ND2006 2.

In plants, LbCas12a is the most commonly used CRISPR nuclease 1 and editing has been successfully performed in Arabidopsis, rice, maize, Nicotiana benthamiana, tomato, citrus, lettuce, cotton, poplar 1 , grapevine 2 , and soybean. Heat treatment can be used to improve the efficiency of LbCas12a editing 1, 2 . Applications include controlling gene expression via promoter destruction 2.

LbCas12a is also highly specific in humans and has an on-target efficiency similar to Streptococcus pyogenes Cas9 3. LbCas12a mediates robust genome editing for both single gene 4 and multiplex targeting 5 in HEK293FT cells and can efficiently induce both insertion and deletion mutations in U2OS human cells 3. The LbCas12a CRISPR system has also been used to develop a molecular diagnostic tool for point-of-care detection of SARS-CoV-2 nucleic acids 6. Additionally, LbCas12a variants are being explored as a potential therapeutic tool in the treatment of cancer and are able to induce efficient gene editing in oncogenes of human cells 7.

Protein Details

Species
lachnospiraceae bacterium
Format
Purified No Carrier Protein
Biological Activity
N/A
Protein Accession No.
A0A5S8WF58
Amino Acid Sequence
SKLEKFTNCYSLSKTLRFKAIPVGKTQENIDNKRLLVEDEKRAEDYKGVKKLLDRYYLSFINDVLHSIKLKNLNNYISLFRKKTRTEKENKELENLEINLRKEIAKAFKGNEGYKSLFKKDIIETILPEFLDDKDEIALVNSFNGFTTAFTGFFDNRENMFSEEAKSTSIAFRCINENLTRYISNMDIFEKVDAIFDKHEVQEIKEKILNSDYDVEDFFEGEFFNFVLTQEGIDVYNAIIGGFVTESGEKIKGLNEYINLYNQKTKQKLPKFKPLYKQVLSDRESLSFYGEGYTSDEEVLEVFRNTLNKNSEIFSSIKKLEKLFKNFDEYSSAGIFVKNGPAISTISKDIFGEWNVIRDKWNAEYDDIHLKKKAVVTEKYEDDRRKSFKKIGSFSLEQLQEYADADLSVVEKLKEIIIQKVDEIYKVYGSSEKLFDADFVLEKSLKKNDAVVAIMKDLLDSVKSFENYIKAFFGEGKETNRDESFYGDFVLAYDILLKVDHIYDAIRNYVTQKPYSKDKFKLYFQNPQFMGGWDKDKETDYRATILRYGSKYYLAIMDKKYAKCLQKIDKDDVNGNYEKINYKLLPGPNKMLPKVFFSKKWMAYYNPSEDIQKIYKNGTFKKGDMFNLNDCHKLIDFFKDSISRYPKWSNAYDFNFSETEKYKDIAGFYREVEEQGYKVSFESASKKEVDKLVEEGKLYMFQIYNKDFSDKSHGTPNLHTMYFKLLFDENNHGQIRLSGGAELFMRRASLKKEELVVHPANSPIANKNPDNPKKTTTLSYDVYKDKRFSEDQYELHIPIAINKCPKNIFKINTEVRVLLKHDDNPYVIGIDRGERNLLYIVVVDGKGNIVEQYSLNEIINNFNGIRIKTDYHSLLDKKEKERFEARQNWTSIENIKELKAGYISQVVHKICELVEKYDAVIALEDLNSGFKNSRVKVEKQVYQKFEKMLIDKLNYMVDKKSNPCATGGALKGYQITNKFESFKSMSTQNGFIFYIPAWLTSKIDPSTGFVNLLKTKYTSIADSKKFISSFDRIMYVPEEDLFEFALDYKNFSRTDADYIKKWKLYSYGNRIRIFRNPKKNNVFDWEEVCLTSAYKELFNKYGINYQQGDIRALLCEQSDKAFYSSFMALMSLMLQMRNSITGRTDVDFLISPVKNSDGIFYDSRNYEAQENAILPKNADANGAYNIARKVLWAIGQFKKAEDEKLDKVKIAISNKEWLEYAQTSVKH
N-terminal Sequence Analysis
NP
State of Matter
Frozen Liquid
SDS-Page Molecular Weight
~150k
Predicted Molecular Mass
143k
Formulation
0.22µm filtered
Reconstitution
Reconstitute at 0.1-1 mg/ml using filtered deionized water. Gently mix by vortexing and/or inversion until fully dissolved. Centrifuge if necessary.
Storage and Stability
1 month, 2 to 8 °C under sterile conditions after opening.
1 year from date of receipt, -20 to -80 °C sterile conditions after opening.
Country of Origin
USA
Shipping
Frozen Dry Ice
Species
lachnospiraceae bacterium
Regulatory Status
Research Use Only
UniProt.org
Applications and Recommended Usage ?
(Quality Tested by Leinco)
WB,
ELISA,
FA

References & Citations

1 Zhang Y, Cheng Y, Fang H, et al. Front Genome Ed. 4:780238. 2022.
2 Ren C, Gathunga EK, Li X, et al. Mol Hortic. 3(1):21. 2023.
3 Kleinstiver BP, Tsai SQ, Prew MS, et al. Nat Biotechnol. 34(8):869-874. 2016.
4 Zetsche B, Gootenberg JS, Abudayyeh OO, et al. Cell. 163(3):759-771. 2015.
5 Zetsche B, Heidenreich M, Mohanraju P, et al. Nat Biotechnol. 35(1):31-34. 2017.
6 Hu M, Zhu D, Zhou X. Methods. 203:259-267. 2022.
7 Choi E, Hwang HY, Kwon E, et al. Mol Ther Nucleic Acids. 30:131-142. 2022.
8 Xu R, Qin R, Li H, et al. Plant Biotechnol J. 15(6):713-717. 2017.
9 Li B, Rui H, Li Y, et al. Plant Biotechnol J. 17(10):1862-1864. 2019.
10 Jia H, Orbović V, Wang N. Plant Biotechnol J. 17(10):1928-1937. 2019.
11 Zhou J, Liu G, Zhao Y, et al. Nat Plants. 9(4):588-604. 2023.
12 Kim H, Kim ST, Ryu J, et al. 8:14406. 2017.
Indirect ELISA Protocol
FA
General Western Blot Protocol

Certificate of Analysis

IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.